Current Issue

2016: Volume 2, Issue 1
Research Article: Mol Enzy Drug Targ (11)
Association of HLA Class I and II Antigens with Vitiligo in Egyptian Population
Author(s): Ayman Elgendy, Eslam Alshawadfy, Eman Ali, Nancy Wadea, Karem Khalil, Osama Alkady, Ahmed Elsaidi
DOI: 10.21767/2572-5475.10011
Abstract | Full-Text | PDF
Review Article: Mol Enzy Drug Targ (12)
Endothelial Dysfunction An Evolving Target in Diabetic Nephropathy
Author(s): Atul Arya, Surbhi Rana , Sumeet Gupta and Lakhwinder Singh
DOI: 10.21767/2572-5475.10012
Abstract | Full-Text | PDF
Research Article: Mol Enzy Drug Targ (13)
Pressure Effect on the Folding of G-Quadruplex DNA Modified with Hexaethylene Glycol
Author(s): Shuntaro Takahashi and Naoki Sugimoto
DOI: 10.21767/2572-5475.10013
Abstract | Full-Text | PDF
Commentary: Mol Enzy Drug Targ (14)
ROR1 is an Intriguing Target for Cancer Therapy
Author(s): Ryan Kolb, Paige Kluz and Weizhou Zhang
DOI: 10.21767/2572-5475.10014
Abstract | Full-Text | PDF
Editorial: Mol Enzy Drug Targ (e104)
The FAH Fold Meets the Krebs Cycle
Author(s): Pidder Jansen-Duerr, Haymo Pircher, Alexander Weiss
DOI: 10.21767/2572-5475.100e104
Full-Text | PDF
Short Communication: Mol Enzyme Drug Targets (15)
The Knockout Punch for HER2 Positive Breast Cancer: Addition of an ADAM10 Inhibitor to the Combination Therapy of Trastuzamab and Lapatinib
Author(s): Marcia L. Moss
DOI: 10.21767/2572-5475.10015
Abstract | Full-Text | PDF
Opinion Article: Mol Enzy Drug Targ (16)
Classification of Enzyme Regulators within Thermodynamic Model of Enzyme Regulation
Author(s): Qinyi Zhao
DOI: 10.21767/2572-5475.10016
Abstract | Full-Text | PDF

Recommended Conferences

Flyer image

Abstracted/Indexed in

  • Google Scholar
  • Publons